Medx Health (MDX.V) Stock Price

Medx Health Price

OTC·CLOSED
0.05
​
Market closed

Revenue at Medx Health has contracted by 8.6% per year over the past 19 years to 473,266.00 CAD. Medx Health's net margin stands at -1,329.2%, down from -945.4% several years earlier.

Medx Health stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medx Health business model & stock analysis

Medx Health Corp, trading under the ticker MDX.V, is a Canadian company headquartered in Mississauga, Ontario. The company went public on February 12, 2008, and operates within the Health Care sector, specifically in the Health Care industry. Medx Health Corp develops, manufactures, and sells medical devices and software. Its primary focus is on skin health, utilizing SIAscopy technology for skin-related screening tools. The company offers a telemedicine platform called SIAscopy on DermSecure, which integrates its SIAscopy scanning technology for web-based operations. Products include SIAMETRICS, SIMSYS, and MoleMate, which are hand-held devices that use light-based technology to examine moles and lesions up to two millimeters beneath the skin surface in a pain-free, non-invasive manner. These devices are designed for the rehabilitation market, providing phototherapy treatments using low-level laser and light-emitting diode technology to address pain and tissue damage. The company's offerings are centered around non-invasive skin screening and phototherapeutic applications, targeting both diagnostic and therapeutic needs within the health care sector. Medx Health Corp's products are intended for medical professionals and patients seeking advanced, non-invasive solutions for skin health management and rehabilitation.

Frequently asked questions about Medx Health

9 analysts currently rate the Medx Health stock: 8 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Medx Health share trades at 0.03 EUR (0.05 CAD).

The revenue cannot currently be calculated for Medx Health.

The expected profit of Medx Health is -6.56 M CAD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Medx Health is currently -2.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medx Health stock.

The P/S cannot be calculated for Medx Health currently.

The Eulerpool Quality Score for Medx Health is 2/10.

The ISIN of Medx Health is CA5850901037. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Medx Health is MDX.V. The ticker symbol is used to trade Medx Health shares on the stock exchange.

Fair ValueTerminal
0.04 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
Feb 12, 2008
ISIN
CA5850901037
Cusip
585090103
Market capitalization
16.40 M CADMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-2.00
P/Ee 2027
—
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
66.31 %
Last updated Oct 19, 2026, 8:35 PM

Medx Health Peer Group

Medx Health Ticker

OTC · MDXHF

Medx Health FIGI

MDXHF:US · BBG000BJS3Q0MDXHF:UV · BBG000BJSDC3MDX:CN · BBG000DWL5B7MDX:CV · BBG000DWL7B3MDX:CJ · BBG000DWL9V7MDX:TV · BBG000DWLCB2MDX:TN · BBG000DWLDP5MDX:TG · BBG000DWLDX6MDX:TK · BBG000DWLFF19MH:GR · BBG00165S2319MH:GB · BBG00165S295MDX:TW · BBG001QLGJ30

All fundamentals and in-depth analysis of Medx Health

Our stock analysis for Medx Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medx Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.